Compliance Training Webinars for Regulated Industries

The Coronavirus known as (COVID 19) has totally disrupted the workplace, where anxiety and the way business is done has changed forever. For many organizations having a plan is the BEST course of action, and with the changing national condition, employers are feeling the growing concerns. As this pandemic continues to unfold each day, there are steps employers can take to manage and minimize chaos in the work environment so employees can continue to be productive and safe at work. This session provides attendees with current helpful tips to address the rapid changing circumstances and concerns in managing the Coronavirus (COVID 19) threat in the workplace.

This webinar is designed to assist the participants in the rapid assimilation of new ideas that can become part of their managerial and leadership repertoire. The notion of "Personal Kaizen" will be introduced in terms of developing, embracing and incorporating new ideas that will bring about changes in behavior. New Idea assimilation will be introduced in terms of a concept called "The Slight Edge".

Volatility, Uncertainty, Complexity, and Ambiguity, otherwise known as VUCA aren’t going away — and confusion will remain part of the mix. The next 10 years will be exceptionally volatile, with many make-or-break decisions to be made. Leaders must do more than just respond to the whirl of events, though respond they must. They must be positive change agents in the midst of chaos, creating the future.

Attend this webinar to understand the new requirements of the medical devices regulation EU IVDR 2017/746 in the European Union and get ready to receive the new certificates until May 2022.

This webinar will illustrate a set of unique tools that simultaneously address challenges of improving awareness, accessibility and compliance with process-related information. Learn how to construct solutions that people across your organization can use to better understand how processes work and how their role fits in, all in ways that complement your existing procedures and document structure. You may also find these tools useful when performing investigations, identifying and mitigating potential risks, and describing a process to a regulatory inspector.

Attend this webinar to learn the best practices of internal control and top twenty internal controls standard roles and responsibilities to detect and prevent fraud. Also attendees will learn top three critical corporate controls and why they are the foundation of any internal controls program.

The webinar will cover requirements for all imported FDA regulated products. Topics covered include required information for FDA’s “Predict” screening program for entry, U.S. Customs Required Information (ACE) program, Harmonized Tariff Schedule, Affirmation of Compliance, and Export Certificate Denial.

This DMFs (Drug Master File) training will discuss the current review and enforcement climate within FDA and the manner in which drug master files (DMFs) are reviewed by FDA personnel. Besides the US, the use of DMFs in the EU, Canada and Australia will also be discussed. Similarities and differences to the U.S. system will be highlighted.

This anti-money laundering training will describe the reasons and methods of money laundering in financial institutions. This will help attendees to protect themselves from regulatory risk by establishing an effective anti-money laundering system within their financial institution.

Recruitment and GDPR are very closely tied since HR managers handle large volumes of candidate data during the hiring and firing processes. Given that infringement can lead to fines of up to 4% of annual worldwide turnover or €20 million, companies need to assess how the GDPR affects their organization. Attend this webinar to learn the new obligations to data processors and data controllers, including those based outside the EU.

The Canadian Drug Approval Process is misunderstood by many and considered harsh by some. We will explore reasons why the Canadian market should not be overlooked and the benefits of including Canada in strategic drug development initiatives. We will share insights and practical examples that facilitate a positive, proactive and transparent interaction with Health Canada, and provide strategies for avoiding obstacles and managing them efficiently should they occur.

This training program will cover in detail the key elements of HPLC and UPLC method validation to ensure compliance with FDA GLP and ISO 17025 requirements.

The coronavirus outbreak has caused thousands of deaths around the world along with extensive economic disruption. China has issued several overt threats to disrupt U.S. supply chains, and the stock market is in turmoil. This presentation will provide information on how organizations can position themselves to handle the disruption and even realize opportunities for improved performance as a result.

Change Management is one of the most critical quality systems a company can have. Well managed systems are effective in implementing desired changes and preventing unwanted modifications to validated processes. This webinar will discuss the requirements for change management, the steps for effective change management and the actions companies can take to ensure unwanted changes do not occur in their operations.

This webinar will illustrate ways to take your ongoing or refresher GMP training to well beyond recycling existing content, regardless of your training budget or available resources. By asking a few simple questions of key stakeholders, and tapping into your already creative process, annual GMP training can start to become more than just something everyone has to complete. Come away with a plan to take your program beyond a year-end box-checking exercise and into a resource that people flock towards.

This webinar will start with a general background about global regulations and then go into detail about specific food additives and how the regulations vary in specific international, regional regulatory and country regulatory documents.